Bengal Physician Journal

Register      Login

VOLUME 9 , ISSUE 3 ( September-December, 2022 ) > List of Articles

Original Article

Gastrointestinal System Adverse Drug Reactions in Geriatric Patients in Odisha

Satyabrata Sahoo, Suhasini Dehury, Dhirendra Nath Maharana, Shambo Samrat Samajdar

Keywords : Adverse drug reaction, Antidiabetic agents, Central nervous system, Elderly, Gastrointestinal, Hospitalized, Upper gastrointestinal bleeding

Citation Information : Sahoo S, Dehury S, Maharana DN, Samajdar SS. Gastrointestinal System Adverse Drug Reactions in Geriatric Patients in Odisha. Bengal Physician Journal 2022; 9 (3):60-63.

DOI: 10.5005/jp-journals-10070-7092

License: CC BY-NC 4.0

Published Online: 06-01-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Aim and objective: Geriatrics is a specialty that deals with the care of the aged. The term “geriatric population” refers to those over 60 years. In India, the elderly make up 8.14% of the population. The pharmacokinetic and pharmacodynamic aspects of the delivered medications are affected by their complicated physiological and pathological profiles. Polypharmacy can lead to various drug–drug interactions and adverse drug reactions (ADRs) in elderly. Gastrointestinal (GI) system ADRs are mostly found in hospitalized elderly. Gastrointestinal ADRs include upper gastrointestinal bleeding (UGI) bleed, diarrhea, etc.; these are the frequent causes of seriousness and hospitalization in geriatric patients. These ADRs are difficult to manage. To prevent ADRs, we need to understand the risk of potential inappropriate prescribing. Deprescribing in appropriate time can prevent medication-related atrocities. Clinical pharmacological reconciliation and review would help us understand anticholinergic burden associated with polypharmacy. Gastrointestinal system ADRs in geriatric patients have been the subject of a small number of research in India, but none have been undertaken in Odisha. Therefore, the aim of this study is to evaluate the GI ADRs that geriatric patients in Odisha experience. Materials and methods: This prospective, hospital-based observational study was carried out by the SCB Medical College and Hospital's Department of Pharmacology and Geriatric Medicine. From August 2016 to July 2018, all elderly patients (aged ≥60 years) with ADR diagnoses were included. The Suspected Adverse Drug Reaction Reporting Form of Indian Pharmacopoeia Commission Version 1.3 was filled out with the ADRs and their features. The prevalence and profile of GI system ADRs were observed. The WHO-UMC System rated their causation, the Hartwig's Severity Scale evaluated their severity, and the Schumock and Thornton Preventability Scale evaluated their preventability. Results: In 2 years, 236 geriatric ADRs were documented, 11% of which involved the GI system. Out of the GI system ADRs, 85% ADRs were found to be in possible category, 92.3% were found to be of moderate in intensity, and 84.6% were found to be probably preventable. The most frequent GI system ADR identified was UGI bleeding caused by nonsteroidal anti-inflammatory drugs (NSAIDs) (61.5%). Conclusion: Most of the ADRs were found to be of moderate intensity according to Hartwig's Severity Scale and probably preventable according to Schumock and Thornton Preventability scale. NSAID-induced UGI bleeding is the major type of GI system ADR found in this study.

  1. Rosario AD and Hans H. World Health Organization. Pharmacovigilance: Ensuring the safe use of medicines. WHO Policy Perspectives on Medicines. Geneva: WHO; 2004.
  2. Pauldurai M. Adverse drug reaction monitoring in geriatric patients of rural teaching hospital. Der Pharmacia Lett 2015;7(12):187–219. 02 January 2015.
  3. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalised patients: A meta-analysis of prospective studies. JAMA 1998;279–215;1200–1205. DOI: 10.1001/jama.279.15.1200.
  4. Mannesse CK, Derkx FH, de Ridder MA, et al. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29(1):35–39. DOI: 10.1093/ageing/29.1.35.
  5. Conforti A, Costantini D, Zanetti F, et al. Adverse drug reactions in older patients: an Italian observational prospective hospital study. Drug, Healthcare Patient Safety 2012:4;75–80. DOI: 10.2147/DHPS.S29287.
  6. Franceschi M, Scarcelli C, Niro V, et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008;31(6):545–556. DOI: 10.2165/00002018-200831060-00009.
  7. Landi F, et al. Adverse drug reactions as cause of hospital admissions: Results from the Italian Group of Pharmacoepidemiology in the elderly (GIFA). J Am Geriatr Soc 2002;50(12):1962–1968. DOI: 10.1046/j.1532-5415.2002.50607.x.
  8. Olivier P, Bertrand L, Tubery M, et al. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging 2009;26(6):475–482. DOI: 10.2165/00002512-200926060-00004.
  9. Devi SLS, Basalingappa S, Abilash SC. A study of adverse drug reactions among elderly patients in a tertiary care hospital. Int J Basic Clin Pharmacol 2017;6(8):1894–1899.
  10. Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997;45(8):945–948. DOI: 10.1111/j.1532-5415.1997.tb02964.x.
  11. Nagaraju MK, Manasa S, Manjunath R. Pharmacovigilance study in geriatric population. Asian J Pharmaceut Clin Res 2015; 8(2): 395–399. 03 February 2015.
  12. Frankfort SV. Am J Geriatr Pharmacother 2009;7(2):93–104. DOI: 10.1016/j.amjopharm.2009.04.006.
  13. D'Cruz S, Sachdev A. J Pharmaceut Health Services Res 2011;2(1): 29–34. http:
  14. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions: A meta-analysis of observational studies. Pharm World Sci 2002;24(2):46–54. DOI: 10.1023/a:1015570104121.
  15. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 49(9):2229–2232. PMID: 1524068.
  16. Samajdar SS, Mukherjee S, Tripathi SK, et al. Deprescribing for better patient outcomes in chronic long term care and role of clinical pharmacological review. J Assoc Physicians India 2021 Nov;69(11): 11–12. PMID: 34781620.
  17. Debjyoti S. Anticholinergic burden in geriatric patients attending clinical pharmacology clinic: A deprescribing cross-sectional study in Eastern India. J Indian Med Assoc 2022;120(10). Assessed on: October 2022.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.